Recombinant Human EGF in Wound Healing: 3D Computational Insights

Year : 2024 | Volume :11 | Issue : 02 | Page : 6-10
By

Sushil Nepali,

Ravi Kumar Chittoria,

Jacob Antony Chakiath,

Kanav Gupta,

Abstract

A Growth Factor represents a naturally-occurring compound with the remarkable ability to incite
cellular growth, proliferation, and differentiation. Typically manifesting as either a protein or a steroid
hormone, these factors wield significant influence over an array of cellular activities. Their pivotal role
lies in the regulation of diverse cellular processes, often serving as catalysts for cell specialization and
maturation, a characteristic that distinguishes them from one another. For instance, bone morphogenic
proteins are renowned for their capacity to ignite the differentiation of bone cells, whereas fibroblast
growth factors and vascular endothelial growth factors are instrumental in orchestrating the
differentiation of blood vessels, a phenomenon known as angiogenesis. These Growth Factors represent
critical signaling molecules that orchestrate the intricate dance of cellular behavior, ensuring the
proper functioning and development of biological systems. Their effects span a spectrum, from
promoting cell division to guiding cells towards specific fates. In essence, they act as molecular
messengers, relaying instructions that shape the landscape of cellular growth and development. The
significance of Growth Factors extends beyond individual cells to encompass broader physiological
processes, such as tissue repair, embryonic development, and immune response modulation. Their
intricate interplay with other molecular players within the cellular milieu underscores their
indispensability in maintaining the delicate balance of biological function. Thus, understanding the
mechanisms underlying Growth Factor activity holds profound implications for fields ranging from
regenerative medicine to cancer therapeutics, offering tantalizing avenues for intervention and
manipulation in the pursuit of improved health outcomes.

Keywords: Wound healing, recombinant human epidermal growth factor, angiogenesis, cytokines

[This article belongs to Research & Reviews: A Journal of Bioinformatics(rrjobi)]

How to cite this article: Sushil Nepali, Ravi Kumar Chittoria, Jacob Antony Chakiath, Kanav Gupta. Recombinant Human EGF in Wound Healing: 3D Computational Insights. Research & Reviews: A Journal of Bioinformatics. 2024; 11(02):6-10.
How to cite this URL: Sushil Nepali, Ravi Kumar Chittoria, Jacob Antony Chakiath, Kanav Gupta. Recombinant Human EGF in Wound Healing: 3D Computational Insights. Research & Reviews: A Journal of Bioinformatics. 2024; 11(02):6-10. Available from: https://journals.stmjournals.com/rrjobi/article=2024/view=157130



References

Nguyen DT, Orgill DP, Murphy GF. The Pathophysiologic Basis for Wound Healing and Cutaneous Regeneration. In: Biomaterials For Treating Skin Loss. Woodhead Publishing (UK/Europe) & CRC Press (US), Cambridge/Boca Raton 2009; 25-57. 2. Stadelmann WK, Digenis AG, Tobin GR. Physiology and healing dynamics of chronic cutaneous wounds. American journal of surgery 1998;176: 83-4. 3. Ueno C, Hunt TK, Hopf HW. Using physiology to improve surgical wound outcomes. Plast Reconstr Surg. Jun 2006;117(7 Suppl):59-71. 4. Abraham JA, Klagsbrun M. Modulation of wound repair by members of the fibroblast growth factor family. In: The Molecular and Cellular Biology ofWound Repair (2nd ed.), edited by Clark RAF. New York: Plenum, 1996; 195 248. 5. Dorland. Growth factor. In: Dorland’s Medical Dictionary 2012. R K Chittoria 5 REVIEW ARTICLE Journal SWCR 2012 6. Yorio T, Clark AF, Wax MB. Ocular Therapeutics. In: Eye on New Discoveries, Academic Press, 2007; 88-92. 7. Mitchell RS, Kumar V, Abbas AK, Fausto N. Table 3-1 In:Robbins Basic Pathology, 8th edition, Philadelphia Saunders, 2007; p2973-77. Embil JM and Nagai MK. Becaplermin: recombinant platelet-derived growth factor, a new treatment for healing diabetic foot ulcers. Exp Opin Biol Ther 2002; 2: 211 218. 9. Steed DL. Modifying the wound healing response with exogenous growth factors. Clin Plast Surg 1998; 25: 397 405. 10. Johnson DE and Williams LT. Structural and functional diversity in the FGF receptor R K Chittoria multigene family. Adv Cancer Res 1993; 60: 141. 11. Massagué J. The transforming growth factor-beta family. Annu Rev Cell Biol 1990; 6: 597641. 12. Romano Di Peppe S, Mangoni A, Zambruno G, Spinetti G, Melillo G, Napolitano M, and Capogrossi MC. Adenovirus-mediated VEGF(165) gene transfer enhances wound healing by promoting angiogenesis in CD1 diabetic mice. Gene Ther 2002; 9: 1271 1277.


Regular Issue Subscription Original Research
Volume 11
Issue 02
Received May 3, 2024
Accepted May 7, 2024
Published July 20, 2024